ArticleThe Journal of clinical investigation2026

Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization.

Sabrina Köcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.